Publication Name	World Journal of Transplantation
Manuscript ID	80235
Country	Pakistan

Received	2022-09-20 13:31
Peer-Review Started	2022-09-20 13:35
To Make the First Decision
Return for Revision	2022-12-13 10:18
Revised	2022-12-21 14:00
Second Decision	2023-01-09 04:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-01-11 00:29
Articles in Press	2023-01-11 00:29
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-01-24 13:51
Typeset the Manuscript	2023-03-15 00:58
Publish the Manuscript Online	2023-03-17 06:08

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pathology
Manuscript Type	Minireviews
Article Title	Transitioning of renal transplant pathology from allograft to xenograft and tissue engineering pathology: Are we prepared?
Manuscript Source	Invited Manuscript
All Author List	Muhammed Mubarak
Funding Agency and Grant Number
Corresponding Author	Muhammed Mubarak, FCPS, Professor, Department of Histopathology, Sindh Institute of Urology and Transplantation, Chand Bibi Road, Karachi 74200, Sindh, Pakistan. drmubaraksiut@yahoo.com
Key Words	Xenotransplantation; Bioengineered tissues; Pathology; Allograft; Xenograft
Core Tip	End-stage organ failure is a significant public health problem worldwide. Currently, treatment options are limited and organ shortage for allotransplantation is one of the biggest challenges. Alternative options being explored are xenografts and engineered/bioengineered tissues/organs. These developments will pose different challenges for the diagnosis and management of transplant pathologies as compared with traditional allografts. The approach to pathologic diagnosis of dysfunction in these settings will likely be significantly different. Thus, there is a need to increase awareness and prepare transplant pathologists to meet this imminent challenge in the field of xenotransplantation/regenerative medicine.
Publish Date	2023-03-17 06:08
Citation	Mubarak M. Transitioning of renal transplant pathology from allograft to xenograft and tissue engineering pathology: Are we prepared? World J Transplant 2023; 13(3): 86-95
URL	https://www.wjgnet.com/2220-3230/full/v13/i3/86.htm
DOI	https://dx.doi.org/10.5500/wjt.v13.i3.86

Full Article (PDF)	WJT-13-86.pdf
Full Article (Word)	WJT-13-86.docx
Manuscript File	80235_Auto_Edited-LM_WangTQ.docx
Answering Reviewers	80235-Answering reviewers.pdf
Audio Core Tip	80235-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	80235-Conflict-of-interest statement.pdf
Copyright License Agreement	80235-Copyright license agreement.pdf
Peer-review Report	80235-Peer-review(s).pdf
Scientific Misconduct Check	80235-Bing-Liu JH-2.jpg
Scientific Misconduct Check	80235-CrossCheck.jpg
Scientific Editor Work List	80235-Scientific editor work list.pdf